rs11654183
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004247.4(EFTUD2):c.994+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,610,700 control chromosomes in the GnomAD database, including 60,129 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004247.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFTUD2 | NM_004247.4 | c.994+6C>T | splice_region_variant, intron_variant | ENST00000426333.7 | NP_004238.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFTUD2 | ENST00000426333.7 | c.994+6C>T | splice_region_variant, intron_variant | 1 | NM_004247.4 | ENSP00000392094.1 |
Frequencies
GnomAD3 genomes AF: 0.262 AC: 39829AN: 151964Hom.: 5280 Cov.: 32
GnomAD3 exomes AF: 0.268 AC: 67339AN: 251090Hom.: 9317 AF XY: 0.269 AC XY: 36500AN XY: 135724
GnomAD4 exome AF: 0.273 AC: 398798AN: 1458618Hom.: 54844 Cov.: 33 AF XY: 0.274 AC XY: 198935AN XY: 725658
GnomAD4 genome AF: 0.262 AC: 39856AN: 152082Hom.: 5285 Cov.: 32 AF XY: 0.262 AC XY: 19459AN XY: 74324
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 20, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mandibulofacial dysostosis-microcephaly syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at